- STAT+: A turning point for pancreatic cancer patientsEli Lilly announces two China deals, Akeso's lung cancer bispecific payoff, and more biotech news from The ReadoutSTAT · 1mo ago↗ source
- CDC says containing the spread of Ebola is top priorityThe Trump administration disregards infectious disease playbook, CEPI offers vaccine funding, and other health news from Morning RoundsSTAT · 1mo ago↗ source
- STAT+: Servier to buy Edgewise Therapeutics’ muscular dystrophy drugThe French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55 billion upfront.STAT · 1mo ago↗ source